Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Real-world, multicenter study of brentuximab vedotin-based regimens in Chinese patients with relapsed/refractory Hodgkin lymphoma

Yuxuan Che, Ruolan Zeng, Dabei Tang, Ou Bai, Youchao Jia, Yuhuan Gao, Xiaojing Yan, Xiaolei Ding, Xiuli Sun, Xiaobo Wang, Bing Xu, Hui-Han Wang, Dongxia Qu, Liye Xu, Na Li, Qingyuan Zhang, Hui Zhou, Xiuhua Sun

Blood (2025) 146 (Supplement 1): 7142.

https://doi.org/10.1182/blood-2025-7142

Published: 2025

Journal Articles

Hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in advanced solid tumors: A multicenter, randomized, double-blind, placebo-controlled phase III trial

Blood (2025) 146 (Supplement 1): 1256.

https://doi.org/10.1182/blood-2025-1256

Published: 2025

Journal Articles

The platelet variability index tool to determine the likelihood of immune thrombocytopenia (ITP): User testing and tool refinement

Syed Mahamad, Na Li, Bianca Clerici, Emily Harris, Rick Ikesaka, Kristine Matusiak, Hayley Merkeley, Donald Arnold

Blood (2025) 146 (Supplement 1): 3037.

https://doi.org/10.1182/blood-2025-3037

Published: 2025

Journal Articles

Cly-124, a first-in-class DCN1 inhibitor partially suppresses CUL3 neddylation and induces fetal hemoglobin is a new potential treatment for sickle cell disease

Blood (2025) 146 (Supplement 1): 837.

https://doi.org/10.1182/blood-2025-837

Published: 2025

Journal Articles

Simplifying Eligibility Criteria for Clinical Trials in Immune Thrombocytopenia Using the Platelet Count Variability Index

Donald Arnold, Yang Liu, Na Li, Madison Cranstone, Syed Mahamad, Ishac Nazy

Blood (2024) 144 (Supplement 1): 2565.

https://doi.org/10.1182/blood-2024-211916

Published: 2024

Journal Articles

Intravenous Albumin Utilization: A Multi-Center Audit of 607,304 Admissions at 16 Hospitals

Nicole Relke, Phuong Uyen Nguyen, Na Li, Sheharyar Raza, Bram Rochwerg, Anne Loeffler, Amol Verma, Fahad Razak, Jeannie Callum

Blood (2024) 144 (Supplement 1): 5596.

https://doi.org/10.1182/blood-2024-201793

Published: 2024

Journal Articles

IL-11 Signaling Drives Clonal Hematopoiesis-Associated Cardiac Dysfunction

Venkatasubramaniam Sundaramurthy, Yue Yuan, Liting Liu, Art Schuermans, Seyedmohammad Saadatagah, Zhi Yu, Alejandra G Martell, Xiaoyan Zhang, Jia Song, Christie M. Ballantyne, Michael C Honigberg, Pradeep Natarajan, Na Li, Margaret Goodell

Blood (2024) 144 (Supplement 1): 948.

https://doi.org/10.1182/blood-2024-208008

Published: 2024

Journal Articles

High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation

Blood (2024) 144 (Supplement 1): 6925.

https://doi.org/10.1182/blood-2024-205155

Published: 2024

Journal Articles

SG301, a Novel Anti-CD38 Monoclonal Antibody, in Patients with Relapsed/Refractory Multiple Myeloma: A First-in-Human, Multicentre, Phase 1 Trial

Blood (2024) 144 (Supplement 1): 4746.

https://doi.org/10.1182/blood-2024-199381

Published: 2024

Journal Articles

Improving Targeted Therapies in Primary CNS Lymphoma: Real-World Use of Cerebrospinal Fluid Circulating Tumor DNA for Monitoring

Ming Jiang, Liqun Zou, Lijie Liang, Yingze Liu, Na Li, You Feng

Blood (2024) 144 (Supplement 1): 1694.

https://doi.org/10.1182/blood-2024-204947

Published: 2024

Journal Articles

Deep learning for platelet transfusion

Na Li, Douglas G. Down

Blood (2023) 142 (26): 2231–2232.

https://doi.org/10.1182/blood.2023022981

Published: 2023

Journal Articles

Evaluating the Impact of Cryopreservation of PBMCs on CAR-T Therapy Efficacy and Safety in DLBCL Patients: An Informative Approach to Optimize Manufacturing Strategies

Teng Xu, Fan Yang, Rui Liu, Zhonghua Fu, Na Li, Xiaoyan Ke, Shaomei Feng, Biping Deng, Kai Hu

Blood (2023) 142 (Supplement 1): 3513.

https://doi.org/10.1182/blood-2023-185590

Published: 2023

Journal Articles

As Fast As We Can: Rational Design of Rapid Chimeric Antigen Receptor T Cell Manufacturing

Pengfei Jiang, Shih-Ting Cao, Haiying Wang, Qinghui Xiong, Mingyuan Gu, Chengbing Fu, Xiu Li, Mian Zhang, Na Li, Jing Li, Xin Xu, Yiwei Gong

Blood (2023) 142 (Supplement 1): 3453.

https://doi.org/10.1182/blood-2023-188144

Published: 2023

Journal Articles

Inflammatory Signaling Mediated By Gasdermin D Underlies Tet2-Mutant Clonal Hematopoiesis-Associated Tissue Dysfunction

Venkatasubramaniam Sundaramurthy, Yue Yuan, Xiaoyan Zhang, Jia Song, Na Li, Margaret Goodell

Blood (2023) 142 (Supplement 1): 1324.

https://doi.org/10.1182/blood-2023-188094

Published: 2023

Journal Articles

From in silico to in Vitro to In Vivo : Increasing Megakaryocytes to Treat Thrombocytopenia

Alejandra Macias, Mauricio Cortes, Na An, Na Li, Timothy Fulton, Allison Simpson, Samuel Miller, Sunny Sun, Doris Fu, Juan Garcia, Satya Medicherla, Scott Steelman, Atli Thorarensen, Matthew Goddeeris, Sriram Krishnamoorthy

Blood (2023) 142 (Supplement 1): 5580.

https://doi.org/10.1182/blood-2023-190250

Published: 2023

Journal Articles

Proinflammatory Cytokine Release and Infusional Side-Effects after Anti-Thymocyte Globulin Serotherapy for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

Rutvij A. Khanolkar, Stephanie Dookie, Na Li, Faisal Khan, Jan Storek

Blood (2023) 142 (Supplement 1): 6782.

https://doi.org/10.1182/blood-2023-189653

Published: 2023

Journal Articles

A Mediator Switch Tunes Transcription Pausing to Drive Erythropoiesis

Hsiang-Ying Lee, Shicong Zhu, Xiaoting Zhang, Man Li, Xinying Zhao, Na Li, Sera Xie, Qiuyu Yue, Yunfeng Li, Dong Li, Fan Wu, Zile Zhang, Ziqi Feng, Yuelin Deng, Qi Hu, Xingyun Yao, Xiaofei Gao

Blood (2023) 142 (Supplement 1): 10.

https://doi.org/10.1182/blood-2023-189195

Published: 2023

Journal Articles

The Protective Role of Tubular Epithelial Cells Produced Fms-like Tyrosine Kinase Receptor 3 Ligand in Acute Kidney Injury

Na Li, Yao Guo, Zheqi Wen, Chuyu Xie, Mingcheng Huang, Jiang Shan, Yuming Zhao, Dengyang Zhang, Zhiguang Chang, Liuting Yu, Chi Kong Li, Zhihua Zheng, Zhizhuang Joe Zhao, Yun Chen

Blood (2023) 142 (Supplement 1): 2539.

https://doi.org/10.1182/blood-2023-174317

Published: 2023

Journal Articles

Pharmacokinetic-Targeting and Dose-Adjustment of I.V. Busulfan for Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation

Rutvij A. Khanolkar, Shahbal B Kangarloo, Na Li, Faisal Khan, Jan Storek

Blood (2023) 142 (Supplement 1): 6980.

https://doi.org/10.1182/blood-2023-190089

Published: 2023

Journal Articles

The Tubular Cells Produce Fms-like Tyrosine Kinase Receptor 3 Ligand to Recover Kidney Function after Acute Kidney Injury Disease

Na Li, Yao Guo, Zhihua Zheng, Yun Chen, Zhizhuang Joe Zhao

Blood (2022) 140 (Supplement 1): 8325.

https://doi.org/10.1182/blood-2022-155704

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Real-world, multicenter study of brentuximab vedotin-based regimens in Chinese patients with relapsed/refractory Hodgkin lymphoma

Hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in advanced solid tumors: A multicenter, randomized, double-blind, placebo-controlled phase III trial

The platelet variability index tool to determine the likelihood of immune thrombocytopenia (ITP): User testing and tool refinement

Cly-124, a first-in-class DCN1 inhibitor partially suppresses CUL3 neddylation and induces fetal hemoglobin is a new potential treatment for sickle cell disease

Simplifying Eligibility Criteria for Clinical Trials in Immune Thrombocytopenia Using the Platelet Count Variability Index

Intravenous Albumin Utilization: A Multi-Center Audit of 607,304 Admissions at 16 Hospitals

IL-11 Signaling Drives Clonal Hematopoiesis-Associated Cardiac Dysfunction

High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation

SG301, a Novel Anti-CD38 Monoclonal Antibody, in Patients with Relapsed/Refractory Multiple Myeloma: A First-in-Human, Multicentre, Phase 1 Trial

Improving Targeted Therapies in Primary CNS Lymphoma: Real-World Use of Cerebrospinal Fluid Circulating Tumor DNA for Monitoring

Deep learning for platelet transfusion

Evaluating the Impact of Cryopreservation of PBMCs on CAR-T Therapy Efficacy and Safety in DLBCL Patients: An Informative Approach to Optimize Manufacturing Strategies

As Fast As We Can: Rational Design of Rapid Chimeric Antigen Receptor T Cell Manufacturing

Inflammatory Signaling Mediated By Gasdermin D Underlies Tet2-Mutant Clonal Hematopoiesis-Associated Tissue Dysfunction

From in silico to in Vitro to In Vivo : Increasing Megakaryocytes to Treat Thrombocytopenia

Proinflammatory Cytokine Release and Infusional Side-Effects after Anti-Thymocyte Globulin Serotherapy for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

A Mediator Switch Tunes Transcription Pausing to Drive Erythropoiesis

The Protective Role of Tubular Epithelial Cells Produced Fms-like Tyrosine Kinase Receptor 3 Ligand in Acute Kidney Injury

Pharmacokinetic-Targeting and Dose-Adjustment of I.V. Busulfan for Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation

The Tubular Cells Produce Fms-like Tyrosine Kinase Receptor 3 Ligand to Recover Kidney Function after Acute Kidney Injury Disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only